New vaccine aims to train immune system to attack breast cancer
⭐️ VACCINE ⭐️
Recruiting now
This early-phase trial tests an investigational vaccine designed to teach the immune system to recognize and attack HER2-positive breast cancer cells. The study includes 36 adults with locally advanced HER2-positive breast cancer. The main goals are to check the vaccine's safety …
Phase: PHASE1 • Sponsor: Pravin T.P Kaumaya • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:13 UTC